Does tryptase contribute to the pathogenesis of equine heaves?

K. Dacre, C. Deaton, D. Marlin, B. McGorum, A. Pemberton (Easter Bush, Kentford, United Kingdom)

Source: Annual Congress 2004 - Animal models of airway diseases
Session: Animal models of airway diseases
Session type: Thematic Poster Session
Number: 2201
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Dacre, C. Deaton, D. Marlin, B. McGorum, A. Pemberton (Easter Bush, Kentford, United Kingdom). Does tryptase contribute to the pathogenesis of equine heaves?. Eur Respir J 2004; 24: Suppl. 48, 2201

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Essential role of sirtuins in the pathogenesis of allergic airway inflammation
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009


Intracellular enzyme profiles of equine lymphocytes isolated from normal horses and horses with heaves - an asthma-like syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 511s
Year: 2002

IL-33 may augment the effect of rhinovirus HRV16 on the inflammatory activity of human lung vascular endothelium – possible implication for asthma exacerbations.
Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man
Year: 2021

Association of sputum chitinase like protein levels with pathophysiology and neutrophilic airway inflammation in asthma
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008


IL-33/sST2 balance regulates neutrophilic inflammation in the human airways.
Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases
Year: 2019

Lymphocyte apoptosis in atopic bronchial asthma: the mechanisms, role in pathogenesis and therapy
Source: Eur Respir J 2004; 24: Suppl. 48, 38s
Year: 2004

IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis
Source: Eur Respir J, 54 (1) 1800174; 10.1183/13993003.00174-2018
Year: 2019



A crucial role for lung interstitial macrophages in preventing airway allergy
Source: Annual Congress 2009 - Infections, immunity and inflammation
Year: 2009

The role of lipoxin A4 and its receptor in pathogenesis of inflammatory lung diseases
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010


Airway mechanical compression: its role in asthma pathogenesis and progression
Source: Eur Respir Rev, 29 (157) 190123; 10.1183/16000617.0123-2019
Year: 2020



Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression
Source: Eur Respir J 2003; 22: 290-297
Year: 2003



Osteopontin blockade prevents fibrosis in a murine chronic model of allergic airway disease
Source: Eur Respir J 2007; 30: Suppl. 51, 60s
Year: 2007

The role of certain regulatory cytokines in the immunopathogenesis of extrinsic allergic alveolitis
Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics
Year: 2018

Airway epithelial cell P2Y6R-Expression is up-regulated during acute and chronic allergic inflammation and contributes via modulating of CXC8 and IL-6 secretion to development of airway remodelling
Source: Annual Congress 2010 - Pre-clinical models of airways disease
Year: 2010



Neurokinins contribute to vascular remodelling in a model of chronic pulmonary allergic inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 760s
Year: 2006

Critical immunoregulatory role for activin-A in human allergic asthma
Source: Annual Congress 2011 - Experimental modulation of airway inflammation
Year: 2011

IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation.
Source: International Congress 2018 – Novel drug targets for asthma and COPD
Year: 2018